calendar
29,027 catalysts · 9,524 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
29,027 catalysts · 9,524 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: RISING. Form: TABLET. Route: ORAL
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PRODS. Form: POWDER. Route: INTRAVENOUS
Sponsor: MSD MERCK CO. Form: POWDER. Route: INTRAVENOUS
Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: JAZZ. Form: POWDER. Route: INTRAVENOUS
Sponsor: KARYOPHARM THERAPS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL
Sponsor: LABORATORIOS GRIFOLS. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: VIELA BIO. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BIOGEN IDEC. Form: SOLUTION. Route: INTRATHECAL
Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL
Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS
Sponsor: QOL MEDCL. Form: SPRAY, METERED. Route: NASAL
Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION
Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION
Sponsor: AM REGENT. Form: INJECTABLE. Route: INJECTION
Sponsor: AM REGENT. Form: INJECTABLE. Route: INJECTION
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL